First Eagle Investment’s BBNX Holdings & Trades

First Buy
Q3 2025
Duration Held
1 Quarters
Largest Add
Q3 2025
+233,202 Shares
Current Position
233,202 Shares
$4.63 M Value

First Eagle Investment's BBNX Position Overview

First Eagle Investment (via First Eagle Investment Management, LLC) currently holds 233,202 shares of Beta Bionics, Inc. (BBNX) worth $4.63 M, representing 0.01% of the portfolio. First purchased in 2025-Q3, this recently established position has been held for 1 quarters.

Based on recent 13F filings, First Eagle Investment has initiated a new position in BBNX, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.

Analysis based on 13F filings available since 2013 Q2

First Eagle Investment's Beta Bionics (BBNX) Holding Value Over Time

Track share changes against reported price movement

Quarterly Beta Bionics (BBNX) Trades by First Eagle Investment

Period Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q3 2025 +233,202 New Buy 233,202 $19.87

First Eagle Investment's Beta Bionics Investment FAQs

First Eagle Investment first purchased Beta Bionics, Inc. (BBNX) in Q3 2025, acquiring 233,202 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

First Eagle Investment has held Beta Bionics, Inc. (BBNX) for 1 quarters since Q3 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

First Eagle Investment's largest addition to Beta Bionics, Inc. (BBNX) was in Q3 2025, adding 233,202 shares worth $4.63 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

According to the latest 13F filing for Q3 2025, First Eagle Investment's firm, First Eagle Investment Management, LLC, owns 233,202 shares of Beta Bionics, Inc. (BBNX), valued at approximately $4.63 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

As of the Q3 2025 filing, Beta Bionics, Inc. (BBNX) represents approximately 0.01% of First Eagle Investment's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

First Eagle Investment's peak holding in Beta Bionics, Inc. (BBNX) was 233,202 shares, as reported at the end of Q3 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.